175 related articles for article (PubMed ID: 9709172)
1. Amyloid, advanced glycation end products, and dialysis related arthropathy.
McDonald SP; Coates PT; Disney AP
Ann Rheum Dis; 1998 Apr; 57(4):193-5. PubMed ID: 9709172
[No Abstract] [Full Text] [Related]
2. New aspects in the pathogenesis of dialysis-related amyloidosis: role of beta 2-microglobulin modified with advanced glycation end products in bone and joint destruction.
Miyata T; Maeda K
Nephrol Dial Transplant; 1996; 11 Suppl 2():140-3. PubMed ID: 8804015
[No Abstract] [Full Text] [Related]
3. Beta2-microglobulin and renal bone disease.
Wada T; Miyata T; Sakai H; Kurokawa K
Perit Dial Int; 1999; 19 Suppl 2():S413-6. PubMed ID: 10406556
[TBL] [Abstract][Full Text] [Related]
4. Dialysis arthropathy.
Lancet; 1988 Jan 2-9; 1(8575-6):27-8. PubMed ID: 2891893
[No Abstract] [Full Text] [Related]
5. Beta 2-microglobulin-related amyloidosis: where do we stand?
Gejyo F; Arakawa M
Nephrol Dial Transplant; 1995; 10(2):155-7. PubMed ID: 7753446
[No Abstract] [Full Text] [Related]
6. Advanced glycation of beta 2-microglobulin in the pathogenesis of bone lesions in dialysis-associated amyloidosis.
Miyata T; Sprague SM
Nephrol Dial Transplant; 1996; 11 Suppl 3():86-90. PubMed ID: 8840320
[No Abstract] [Full Text] [Related]
7. Beta2-Microglobulin dialysis amyloid and its formation: role of 3-deoxyglucosone and advanced glycation end products.
Niwa T
Nephron; 1997; 76(4):373-91. PubMed ID: 9274834
[No Abstract] [Full Text] [Related]
8. Beta 2-microglobulin modified with the AGE products of the Maillard reaction in dialysis-related amyloidosis.
Miyata T; Wada Y; Maeda K
Contrib Nephrol; 1995; 112():52-64. PubMed ID: 7554993
[No Abstract] [Full Text] [Related]
9. [Amyloidosis in patients undergoing long-term hemodialysis: elucidation of etiological mechanism and therapeutic stratigy].
Shimojyo F
Nihon Naika Gakkai Zasshi; 2005 Feb; 94 Suppl():56-60. PubMed ID: 15796057
[No Abstract] [Full Text] [Related]
10. Diagnosis, pathogenesis, and treatment of dialysis-related amyloidosis.
Miyata T; Inagi R; Kurokawa K
Miner Electrolyte Metab; 1999; 25(1-2):114-7. PubMed ID: 10207272
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of dialysis-related amyloidosis.
Miyata T; Maeda K
Curr Opin Nephrol Hypertens; 1995 Nov; 4(6):493-7. PubMed ID: 8591057
[TBL] [Abstract][Full Text] [Related]
12. Molecular heterogeneity of amyloid beta2-microglobulin and modification with advanced glycation end products.
Mironova R; Niwa T
J Chromatogr B Biomed Sci Appl; 2001 Jul; 758(1):109-15. PubMed ID: 11482729
[TBL] [Abstract][Full Text] [Related]
13. Aluminium and dialysis associated arthropathy.
Netter P; Kessler M; Gaucher A; Burnel D; Fener P
Nephron; 1991; 59(4):669. PubMed ID: 1766513
[No Abstract] [Full Text] [Related]
14. Interaction between beta 2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis.
Hou FF; Chertow GM; Kay J; Boyce J; Lazarus JM; Braatz JA; Owen WF
Kidney Int; 1997 May; 51(5):1514-9. PubMed ID: 9150467
[TBL] [Abstract][Full Text] [Related]
15. Alterations of synovial tissue and their potential role in the deposition of beta2-microglobulin-associated amyloid.
Ehlerding G; Schaeffer J; Drommer W; Miyata T; Koch KM; Floege J
Nephrol Dial Transplant; 1998 Jun; 13(6):1465-75. PubMed ID: 9641177
[TBL] [Abstract][Full Text] [Related]
16. Implication of the glycoxidation and lipoxidation reactions in the pathogenesis of dialysis-related amyloidosis (Review).
Sugiyama S; Miyata T; Inagi R; Kurokawa K
Int J Mol Med; 1998 Nov; 2(5):561-5. PubMed ID: 9858652
[TBL] [Abstract][Full Text] [Related]
17. Dialysis-related beta 2 microglobulin-amyloid arthropathy. Improvement of clinical symptoms after a switch of dialysis membranes.
Hardouin P; Flipo RM; Foissac-Gegoux P; Dumont A; Duquesnoy B; Delcambre B
Clin Rheumatol; 1988 Mar; 7(1):41-5. PubMed ID: 3044672
[TBL] [Abstract][Full Text] [Related]
18. Monocyte/macrophage response to beta 2-microglobulin modified with advanced glycation end products.
Miyata T; Iida Y; Ueda Y; Shinzato T; Seo H; Monnier VM; Maeda K; Wada Y
Kidney Int; 1996 Feb; 49(2):538-50. PubMed ID: 8821842
[TBL] [Abstract][Full Text] [Related]
19. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis.
Miyata T; Hori O; Zhang J; Yan SD; Ferran L; Iida Y; Schmidt AM
J Clin Invest; 1996 Sep; 98(5):1088-94. PubMed ID: 8787669
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical localization of beta 2-microglobulin and advanced glycation end products in amyloid-enriched carpal tunnel ligament.
Morita H; Shinzato T; Cai Z; Horiuchi S; Maeda K
Nephron; 1996; 73(1):117-8. PubMed ID: 8742979
[No Abstract] [Full Text] [Related]
[Next] [New Search]
